Rankings
▼
Calendar
IDXX Q4 2023 Earnings — IDEXX Laboratories, Inc. Revenue & Financial Results | Market Cap Arena
IDXX
IDEXX Laboratories, Inc.
$48B
Q4 2023 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$902M
+8.8% YoY
Gross Profit
$526M
58.4% margin
Operating Income
$245M
27.2% margin
Net Income
$195M
21.6% margin
EPS (Diluted)
$2.32
QoQ Revenue Growth
-1.5%
Cash Flow
Operating Cash Flow
$250M
Free Cash Flow
$217M
Stock-Based Comp.
$15M
Balance Sheet
Total Assets
$3.3B
Total Liabilities
$1.8B
Stockholders' Equity
$1.5B
Cash & Equivalents
$454M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$902M
$829M
+8.8%
Gross Profit
$526M
$485M
+8.5%
Operating Income
$245M
$227M
+8.3%
Net Income
$195M
$172M
+13.0%
Revenue Segments
Product
$1.0B
57%
Service
$774M
43%
Geographic Segments
UNITED STATES
$576M
57%
Asia Pacific
$186M
19%
EMEA
$184M
18%
CANADA
$37M
4%
Latin America
$22M
2%
← FY 2023
All Quarters
Q1 2024 →